Skip to main content

Table 2 Patient mean survival time and Cox regression analysis of TMPRSS2-ERG fusion status

From: Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

Fusion Status Survival Time (SD)1 HR (95% CI)2 p-value HR (95% CI)3 p-value
Negative 11.4 (3.1)     
   Positive 12.0 (2.6) 2.4 (0.7 – 7.6) 0.3 1.2 (0.3 – 4.0) 0.8
Negative 11.4 (3.1)     
   Translocation 12.0 (2.9)     
   Deletion 12.0 (2.2) 1.5 (0.7 – 2.9) 0.3 1.2 (0.5 – 2.7) 0.5
Negative 11.4 (3.1)     
   Single 12.1 (2.3)     
   Multiple 11.5 (4.1) 1.9 (0.9 – 4.1) 0.09 1.5 (0.6 – 3.9) 0.9
  1. 1Time elapsed from diagnosis until death; 2Age adjusted; 3Age & Gleason score adjusted.